copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Genomics - Global - World Health Organization (WHO) Genomics is evolving rapidly, and its potential impact for the future of human health cannot yet be known Human genomics knowledge and technologies provide new ways to prevent and manage many diseases, and opportunities to achieve global public health goals Genomic knowledge of other organisms contributes to the understanding of human health and diseases, the interconnectedness across
WHO releases new principles for ethical human genomic data collection . . . The World Health Organization (WHO) has issued a set of principles for the ethical collection, access, use and sharing of human genomic data Created with guidance from the WHO Technical Advisory Group on Genomics (TAG-G) and other international experts, these principles establish a global approach to help protect individual rights, promote equity and foster responsible collaboration in
News - World Health Organization (WHO) Abortion: Safety Accessing and implementing GCF readiness funds Addictive behaviours: Gaming disorder Adolescent health and development Adolescent sexual and reproductive health Ageing: Ageism Ageing: Global population Air pollution: Personal interventions and risk communication Air pollution: Reducing short-lived climate pollutants Antibiotic resistance: Why vaccination is important
Technical Advisory Group on Genomics (TAG-G) The Technical Advisory Group on Genomics (TAG-G) provides independent, strategic advice to WHO around technical areas relating to enhancing access to genomic knowledge and technologies for global health
WHO global genomic surveillance strategy for pathogens with pandemic . . . The Strategy provides a high-level unifying framework to leverage existing capacities, address barriers and strengthen the use of genomic surveillance in the detection, monitoring and response to public health threats Genomic surveillance is part of the broader surveillance and laboratory system, and its implementation should reinforce end-to-end capacities including sample collection
Consultation on WHO principles for human genome data access and sharing For the potential of genomics to be realized, access to, and the sharing of, human genome data is critical Following WHO’s Science Council 2022 Report on Accelerating access to genomics for global health: promotion, implementation, collaboration, and ethical, legal, and social issues, WHO is implementing a programme of activities to promote equitable and fair access to genomics technologies
Guidance for human genome data collection, access, use and sharing The WHO’s new document outlines a comprehensive set of globally applicable principles designed to guide stakeholders in the responsible collection, use, and sharing of human genome data This document serves as a key resource to navigate complex issues surrounding data governance, with the aim of fostering transparency, promoting equity, and safeguarding individual and collective rights
Genomics costing tool - World Health Organization (WHO) The first edition of the genomics costing tool (GCT) facilitates budgeting and resource mobilization for infrastructure, workforce, biosafety and quality assurance associated with SARS-CoV-2 genomic surveillance This tool will be useful to country, regional and global policymakers, health administrators and economists, laboratory directors, quality managers, donor institutions and other
A milestone in public health and disease surveillance: Fiji launches . . . In a major advancement in public health in the Pacific, Fiji has launched its Pathogen Genomics Laboratory The state-of-the-art facility, based at the Fiji Centre for Disease Control, marks a historic milestone in the country’s ability to rapidly detect, characterize, and respond to infectious disease threats - from antimicrobial-resistant bacteria to viral diseases like influenza, COVID-19